Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLRN | NVCT | PLX | ||
| Company | Acelyrin Inc | Nuvectis Pharma Inc | Protalix Biotherapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 2.24 | 8.86 | 2.86 | ||
| High | 2.36 | 9.16 | 2.94 | ||
| Low | 2.20 | 8.70 | 2.82 | ||
| Latest | 2.27 | 9.03 | 2.83 | ||
| Change | +0.04 | +0.32 | unch | ||
| % Change | +1.79% | +3.67% | unch | ||
| Volume | 4,076,500 | 63,700 | 685,200 | ||
| 20-Day Average Volume | 1,091,300 | 55,955 | 1,692,630 | ||
| Previous Close | 2.23 | 8.71 | 2.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.33 | 8.76 | 2.94 | ||
| 20-Day Raw Stochastic | 45.16% | 82.61% | 34.55% | ||
| 20-Day Relative Strength | 47.29 | 57.51 | 56.49 | ||
| Weighted Alpha | -28.45 | +32.48 | +73.09 | ||
| Today's Opinion | 88% Sell | 88% Buy | 88% Buy | ||
| Previous Opinion | 88% Sell | 72% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Sell | 72% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.61% since 05/13/25 | +1.12% since 02/25/26 | -6.60% since 02/25/26 | ||
| Low | 1.95 on 05/15/25 | 8.63 on 03/03/26 | 2.78 on 03/02/26 | ||
| High | 2.36 on 05/20/25 | 9.16 on 03/04/26 | 3.05 on 03/02/26 | ||
| 1-Month | |||||
| %Chg | +3.18% since 04/17/25 | +6.74% since 02/04/26 | -2.41% since 02/04/26 | ||
| Low | 1.95 on 05/15/25 | 8.12 on 02/11/26 | 2.64 on 02/10/26 | ||
| High | 2.65 on 05/01/25 | 9.23 on 02/13/26 | 3.19 on 02/23/26 | ||
| 3-Month | |||||
| %Chg | +4.61% since 02/20/25 | +33.88% since 12/04/25 | +61.71% since 12/04/25 | ||
| Low | 1.95 on 05/15/25 | 6.47 on 12/09/25 | 1.68 on 12/08/25 | ||
| High | 2.94 on 04/02/25 | 9.44 on 01/08/26 | 3.19 on 02/23/26 | ||
| 6-Month | |||||
| %Chg | -48.76% since 11/20/24 | +38.50% since 09/04/25 | +77.99% since 09/04/25 | ||
| Low | 1.85 on 02/11/25 | 5.55 on 11/07/25 | 1.52 on 09/05/25 | ||
| High | 5.03 on 11/25/24 | 9.44 on 01/08/26 | 3.19 on 02/23/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 229,166 | 230,745 | 227,591 | ||
| Shares Outstanding, K | 100,954 | 26,492 | 80,421 | ||
| Annual Sales | 0 | 0 | 53,400,000 | ||
| Annual Net Income | -248,230,000 | -26,440,000 | 2,930,000 | ||
| Last Quarter Sales | 0 | 0 | 17,850,000 | ||
| Last Quarter Net Income | -55,260,000 | -7,310,000 | 2,360,000 | ||
| 60-Month Beta | 1.07 | -0.31 | -0.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 05/14/25 | -0.44 on 11/04/25 | 0.03 on 11/13/25 | ||
| Latest Earnings Date | 08/12/25 | 05/05/26 | 03/16/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 43.29 | ||